Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/18/26 16:12 | 3/16/26 | IRD | Health | Drug | Pharmaceutical Preparations | Schachle Joseph K | NC | O | COO | S | -20 | 5.25 | 0 | -4 | -1 | 301 | D | ||||||||||||||
3/18/26 16:11 | 3/16/26 | IRD | Health | Drug | Pharmaceutical Preparations | Zaremba Rabourn Amy | NC | O | Head of | S | -15 | 5.25 | 0 | -3 | -1 | 190 | D | ||||||||||||||
3/18/26 16:10 | 3/16/26 | IRD | Health | Drug | Pharmaceutical Preparations | Magrath George | NC | DO | CEO | S | -127 | 5.21 | 0 | -24 | -1 | 1,751 | D | ||||||||||||||
3/18/26 16:09 | 3/16/26 | IRD | Health | Drug | Pharmaceutical Preparations | Jayagopal Ashwath | NC | O | Chief Sc | S | -19 | 5.12 | 0 | -4 | -1 | 517 | D | ||||||||||||||
12/11/25 17:35 | 12/9/25 | IRD | Health | Drug | Pharmaceutical Preparations | Foundation Fighting Blindness Retinal Degeneration Fund | NC | DH | See Rema | S | -8,600 | 2.15 | 0 | -4,000 | -42 | 5,492 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |